Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease
HPLC was employed to profile the alkaloidal and non-alkaloidal components of the aqueous extract of B. caapi. The extracts were simultaneously tested in vitro for inhibition of human MAO-A and antioxidant activity in order to correlate phytochemical composition of the extracts and bioactivities. Ban...
Gespeichert in:
Veröffentlicht in: | Journal of ethnopharmacology 2010-04, Vol.128 (3), p.662-671 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | HPLC was employed to profile the alkaloidal and non-alkaloidal components of the aqueous extract of
B. caapi. The extracts were simultaneously tested
in vitro for inhibition of human MAO-A and antioxidant activity in order to correlate phytochemical composition of the extracts and bioactivities.
Banisteriopsis caapi, a woody vine from the Amazonian basin, is popularly known as an ingredient of a sacred drink ayahuasca, widely used throughout the Amazon as a medicinal tea for healing and spiritual exploration. The usefulness of
Banisteriopsis caapi has been established for alleviating symptoms of neurological disorders including Parkinson's disease.
Primary objective of this study was to develop the process for preparing standardized extracts of
Banisteriopsis caapi to achieve high potency for inhibition of human monoamine oxidases (MAO) and antioxidant properties. The aqueous extracts prepared from different parts of the plant collected from different geographical locations and seasons were analyzed by HPLC for principal bioactive markers. The extracts were simultaneously tested
in vitro for inhibition of human MAOs and antioxidant activity for analysis of correlation between phytochemical composition of the extracts and bioactivities.
Reversed-phase HPLC with photodiode array detection was employed to profile the alkaloidal and non-alkaloidal components of the aqueous extract of
Banisteriopsis caapi. The
Banisteriopsis caapi extracts and standardized compositions were tested
in vitro for inhibition of recombinant preparations of human MAO-A and MAO-B.
In vitro cell-based assays were employed for evaluation of antioxidant property and mammalian cell cytotoxicity of these preparations.
Among the different aerial parts, leaves, stems/large branches and stem bark of
Banisteriopsis caapi, HPLC analysis revealed that most of the dominant chemical and bioactive markers (1, 2, 5, 7–9) were present in high concentrations in dried bark of large branch. A library of HPLC chromatograms has also been generated as a tool for fingerprinting and authentication of the studied
Banisteriopsis caapi species. The correlation between potency of MAO inhibition and antioxidant activity with the content of the main active constituents of the aqueous
Banisteriopsis caapi extracts and standardized compositions was established. Phytochemical analysis of regular/commercial
Banisteriopsis caapi dried stems, obtained from different sources, showed a similar qualitative HPLC profile, bu |
---|---|
ISSN: | 0378-8741 1872-7573 |
DOI: | 10.1016/j.jep.2010.02.013 |